アナフィラキシーの世界市場レポート 2025年

アナフィラキシー市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.2％で48億1,000万米ドルに成長します。予測期間の成長は、アナフィラキシー症例の発生率上昇に寄与している都市化の進展やライフスタイルの変化など、いくつかの主要要因に起因しています。また、新興市場における可処分所得の増加により、より多くの人々がアレルギー治療や医薬品を利用できるようになっています。アレルギー研究に対する政府からの資金援助は、技術革新と治療選択肢の改善に拍車をかけると予想されます。さらに、自動注射器などの緊急治療用デリバリーシステムの進歩により、アナフィラキシーをより効果的に管理しやすくなっています。予測期間における主な動向としては、注射可能な自動注射器の需要拡大、アナフィラキシーを監視・管理するためのデジタルヘルスソリューションの統合、治療の低価格化への注力、予防的治療やワクチンの開発、アレルギー治療における生物製剤の使用拡大などが挙げられます。

食物アレルギーの有病率の増加は、今後数年間のアナフィラキシー市場の成長を促進すると予想されます。食物アレルギーは、特定の食物によって引き起こされる免疫系反応であり、生命を脅かすアナフィラキシーを含む軽度から重度までの症状を引き起こします。食物アレルギーの有病率の上昇は、食習慣の変化、環境の影響、認識と診断の向上などの要因に起因します。アナフィラキシー治療は、食物アレルギー患者に救命的介入を提供し、重篤なアレルギー反応を迅速に回復させ、腫脹、呼吸困難、血圧低下などの症状を緩和し、即座に安定化させ、致命的となりうる結果を防止するという重要な役割を果たします。また、将来のアレルギー発症時にタイムリーな行動をとるためのツールを患者に提供します。例えば、2024年9月、世界保健機関（WHO）は、世界中で約2億2,000万人が食物アレルギーの影響を受けていると報告しました。ひとつの製品タイプに複数のアレルゲンが含まれることもあり、複数の種類の食品にアレルギーがある場合もあります。さらに、食品基準庁（FSA）は2024年5月に報告書を発表し、英国の成人の30％以上が食品関連の副作用を経験しており、臨床評価では英国の成人の約6％（約240万人）に食物アレルギーが確認されたことを明らかにしました。このように、食物アレルギーの有病率の増加がアナフィラキシー市場の成長を促進しています。

アナフィラキシー市場の企業は、緊急時に迅速かつ効率的なドラッグデリバリーを可能にするエピネフリン点鼻薬の開発など、治療の発展に注力しています。エピネフリン点鼻スプレーは、アナフィラキシーを含む重篤なアレルギー反応の治療薬として、エピネフリン（アドレナリン）を鼻腔から投与する医療機器です。例えば、2024年8月、米国のバイオテクノロジー企業であるARS Pharmaceuticals社は、Neffy（エピネフリン点鼻スプレー）が米国食品医薬品局（FDA）から承認を受け、アナフィラキシーを含むi型アレルギー反応に対する最初で唯一の針を使わない治療薬となったと発表しました。この革新的な鼻腔スプレーは、従来のエピネフリン自動注射器に代わる非侵襲的な代替療法を提供し、緊急治療のより身近な選択肢となる可能性があります。Neffyは、針を刺す必要性をなくすと同時に、重篤なアレルギー反応時に迅速かつ救命的なエピネフリンを提供することで、患者のコンプライアンスを向上させることを目指しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界アナフィラキシーPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のアナフィラキシー市場：成長率分析
• 世界のアナフィラキシー市場の実績：規模と成長, 2019-2024
• 世界のアナフィラキシー市場の予測：規模と成長, 2024-2029, 2034F
• 世界アナフィラキシー総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のアナフィラキシー市場：薬剤クラス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• エピネフリン
• ステロイド
• 抗ヒスタミン薬
• β拮抗薬
• その他の薬物クラス
• 世界のアナフィラキシー市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 非経口
• オーラル
• その他の投与経路
• 世界のアナフィラキシー市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 食物アレルギー
• 花粉アレルギー
• ダニアレルギー
• その他の用途
• 世界のアナフィラキシー市場エピネフリンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 自動注射器
• プレフィルドシリンジ
• バイアル
• 世界のアナフィラキシー市場ステロイドの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• コルチコステロイド
• グルココルチコイド
• ミネラルコルチコイド
• 世界のアナフィラキシー市場抗ヒスタミン薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• H1受容体拮抗薬
• H2受容体拮抗薬
• 世界のアナフィラキシー市場、β拮抗薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 選択的β遮断薬
• 非選択的β遮断薬
• 世界のアナフィラキシー市場、その他の薬物クラスのタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ロイコトリエン受容体拮抗薬
• 肥満細胞安定剤

第7章 地域別・国別分析

• 世界のアナフィラキシー市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のアナフィラキシー市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• アナフィラキシー市場：競合情勢
• アナフィラキシー市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sanofi SA
• AstraZeneca plc
• Abbott Laboratories
• GlaxoSmithKline Plc
• F. Hoffman-La Roche Ltd.
• Teva Pharmaceutical Industries Ltd.
• Bausch Health Companies Inc.
• Perrigo Company plc
• Dr Reddy's Laboratories Ltd.
• Cipla Ltd.
• Amneal Pharmaceuticals Inc.
• Mylan N.V.
• ALK-Abello
• Stallergenes Greer
• Allergy Therapeutics

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• アナフィラキシー市場2029：新たな機会を提供する国
• アナフィラキシー市場2029：新たな機会を提供するセグメント
• アナフィラキシー市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Anaphylaxis is a rapid, severe allergic reaction that can be life-threatening, leading to symptoms such as difficulty breathing, swelling, and a drop in blood pressure. It requires urgent medical attention, with epinephrine being the primary treatment to reverse the effects. After the administration of epinephrine, patients are monitored in a healthcare setting to stabilize their condition and avoid complications.

The main drug classes used in the management of anaphylaxis include epinephrine, steroids, antihistamines, beta-antagonists, and others. Epinephrine is crucial in reversing severe allergic reactions by constricting blood vessels, relaxing airway muscles, and increasing heart rate. These medications are administered through different routes such as parenteral, oral, and others, and are used to treat various types of allergic reactions, including those caused by food allergies, pollen, dust mites, and more.

The anaphylaxis market research report is one of a series of new reports from The Business Research Company that provides anaphylaxis market statistics, including anaphylaxis industry global market size, regional shares, competitors with an anaphylaxis market share, detailed anaphylaxis market segments, market trends and opportunities, and any further data you may need to thrive in the anaphylaxis industry. This anaphylaxis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The anaphylaxis market size has grown strongly in recent years. It will grow from $3.24 billion in 2024 to $3.51 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth during the historic period can be attributed to several factors, including the rising prevalence of food allergies, which has led to more cases of anaphylaxis. Increased awareness of anaphylaxis and its potential risks has contributed to better understanding and faster responses to allergic reactions.

The anaphylaxis market size is expected to see strong growth in the next few years. It will grow to $4.81 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to several key factors, including increasing urbanization and lifestyle changes, which are contributing to a higher incidence of anaphylaxis cases. Rising disposable incomes in emerging markets are also enabling more people to access allergy treatments and medications. Government funding for allergy research is expected to spur innovation and improve treatment options. Additionally, advancements in delivery systems for emergency treatments, such as auto-injectors, are making it easier to manage anaphylaxis more effectively. Major trends in the forecast period include a growing demand for injectable auto-injectors, integration of digital health solutions to monitor and manage anaphylaxis, a focus on making treatments more affordable, the development of preventative treatments and vaccines, and the increased use of biologics in allergy treatment.

The increasing prevalence of food allergies is expected to drive the growth of the anaphylaxis market in the coming years. Food allergies are immune system reactions triggered by certain foods, causing symptoms that can range from mild to severe, including life-threatening anaphylaxis. The rising prevalence of food allergies can be attributed to factors such as changing dietary habits, environmental influences, and improved awareness and diagnosis. Anaphylaxis treatment plays a crucial role in providing life-saving intervention for food allergy patients, rapidly reversing severe allergic reactions, alleviating symptoms such as swelling, difficulty breathing, and a drop in blood pressure, ensuring immediate stabilization, and preventing potentially fatal outcomes. It also equips patients with tools for timely action in future allergic incidents. For example, in September 2024, the World Health Organization (WHO) reported that around 220 million people worldwide are affected by food allergies. A single food product can contain multiple allergens, and individuals may be allergic to more than one type of food. Additionally, the Food Standards Agency (FSA) released a report in May 2024 revealing that over 30% of adults in the UK experienced food-related adverse reactions, and clinical assessments confirmed food allergies in approximately 6% of UK adults, which equals around 2.4 million people. Thus, the increasing prevalence of food allergies is driving growth in the anaphylaxis market.

Companies in the anaphylaxis market are focused on advancing treatments, including the development of epinephrine nasal sprays that allow for faster and more efficient drug delivery in emergencies. Epinephrine nasal sprays are medical devices that administer epinephrine (adrenaline) through the nasal passages as a treatment for severe allergic reactions, including anaphylaxis. For example, in August 2024, ARS Pharmaceuticals, a US-based biotechnology company, announced that Neffy (epinephrine nasal spray) received approval from the US Food and Drug Administration (FDA), making it the first and only needle-free treatment for type I allergic reactions, including anaphylaxis. This innovative nasal spray provides a non-invasive alternative to traditional epinephrine autoinjectors, offering a potentially more accessible option for emergency treatment. Neffy aims to improve patient compliance by eliminating the need for needles while providing rapid, life-saving epinephrine during severe allergic reactions.

In October 2023, Nestle Health Science SA, a Switzerland-based nutritional science company, partnered with Anaphylaxis UK to support individuals with severe allergies. This collaboration is designed to raise awareness about the serious consequences of anaphylaxis and empower individuals to manage allergies safely by providing education and resources. Anaphylaxis UK is a UK-based charity focused on severe allergies.

Major players in the anaphylaxis market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline Plc, F. Hoffman-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Perrigo Company plc, Dr Reddy's Laboratories Ltd., Cipla Ltd., Amneal Pharmaceuticals Inc., Mylan N.V., ALK-Abello, Stallergenes Greer, Allergy Therapeutics.

North America was the largest region in the anaphylaxis market in 2024. The regions covered in anaphylaxis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the anaphylaxis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The anaphylaxis market consists of syringes and vials, intravenous (IV) epinephrine, diagnostic kits, and monitoring devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Anaphylaxis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on anaphylaxis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for anaphylaxis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The anaphylaxis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Class: Epinephrine; Steroids; Antihistamines; Beta-antagonists; Other Drug Class
• 2) By Route Of Administration: Parenteral; Oral; Other Routes Of Administration
• 3) By Application: Food Allergy; Pollen Allergy; Dust Mites Allergy; Other Applications
• Subsegments:
• 1) By Epinephrine: Auto-injectors; Prefilled Syringes; Vials
• 2) By Steroids: Corticosteroids; Glucocorticoids; Mineralocorticoids
• 3) By Antihistamines: H1-receptor Antagonists; H2-receptor Antagonists
• 4) By Beta-antagonists: Selective Beta-blockers; Non-selective Beta-blockers
• 5) By Other Drug Class: Leukotriene Receptor Antagonists; Mast Cell Stabilizers
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Merck & Co. Inc.; Bayer AG; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Anaphylaxis Market Characteristics

3. Anaphylaxis Market Trends And Strategies

4. Anaphylaxis Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Anaphylaxis Growth Analysis And Strategic Analysis Framework

• 5.1. Global Anaphylaxis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Anaphylaxis Market Growth Rate Analysis
• 5.4. Global Anaphylaxis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Anaphylaxis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Anaphylaxis Total Addressable Market (TAM)

6. Anaphylaxis Market Segmentation

• 6.1. Global Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Epinephrine
• Steroids
• Antihistamines
• Beta-antagonists
• Other Drug Class
• 6.2. Global Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Parenteral
• Oral
• Other Routes Of Administration
• 6.3. Global Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Food Allergy
• Pollen Allergy
• Dust Mites Allergy
• Other Applications
• 6.4. Global Anaphylaxis Market, Sub-Segmentation Of Epinephrine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Auto-injectors
• Prefilled Syringes
• Vials
• 6.5. Global Anaphylaxis Market, Sub-Segmentation Of Steroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Corticosteroids
• Glucocorticoids
• Mineralocorticoids
• 6.6. Global Anaphylaxis Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• H1-receptor Antagonists
• H2-receptor Antagonists
• 6.7. Global Anaphylaxis Market, Sub-Segmentation Of Beta-antagonists, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Selective Beta-blockers
• Non-selective Beta-blockers
• 6.8. Global Anaphylaxis Market, Sub-Segmentation Of Other Drug Class, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Leukotriene Receptor Antagonists
• Mast Cell Stabilizers

7. Anaphylaxis Market Regional And Country Analysis

• 7.1. Global Anaphylaxis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Anaphylaxis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Anaphylaxis Market

• 8.1. Asia-Pacific Anaphylaxis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Anaphylaxis Market

• 9.1. China Anaphylaxis Market Overview
• 9.2. China Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Anaphylaxis Market

• 10.1. India Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Anaphylaxis Market

• 11.1. Japan Anaphylaxis Market Overview
• 11.2. Japan Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Anaphylaxis Market

• 12.1. Australia Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Anaphylaxis Market

• 13.1. Indonesia Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Anaphylaxis Market

• 14.1. South Korea Anaphylaxis Market Overview
• 14.2. South Korea Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Anaphylaxis Market

• 15.1. Western Europe Anaphylaxis Market Overview
• 15.2. Western Europe Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Anaphylaxis Market

• 16.1. UK Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Anaphylaxis Market

• 17.1. Germany Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Anaphylaxis Market

• 18.1. France Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Anaphylaxis Market

• 19.1. Italy Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Anaphylaxis Market

• 20.1. Spain Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Anaphylaxis Market

• 21.1. Eastern Europe Anaphylaxis Market Overview
• 21.2. Eastern Europe Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Anaphylaxis Market

• 22.1. Russia Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Anaphylaxis Market

• 23.1. North America Anaphylaxis Market Overview
• 23.2. North America Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Anaphylaxis Market

• 24.1. USA Anaphylaxis Market Overview
• 24.2. USA Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Anaphylaxis Market

• 25.1. Canada Anaphylaxis Market Overview
• 25.2. Canada Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Anaphylaxis Market

• 26.1. South America Anaphylaxis Market Overview
• 26.2. South America Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Anaphylaxis Market

• 27.1. Brazil Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Anaphylaxis Market

• 28.1. Middle East Anaphylaxis Market Overview
• 28.2. Middle East Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Anaphylaxis Market

• 29.1. Africa Anaphylaxis Market Overview
• 29.2. Africa Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Anaphylaxis Market Competitive Landscape And Company Profiles

• 30.1. Anaphylaxis Market Competitive Landscape
• 30.2. Anaphylaxis Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Anaphylaxis Market Other Major And Innovative Companies

• 31.1. Sanofi SA
• 31.2. AstraZeneca plc
• 31.3. Abbott Laboratories
• 31.4. GlaxoSmithKline Plc
• 31.5. F. Hoffman-La Roche Ltd.
• 31.6. Teva Pharmaceutical Industries Ltd.
• 31.7. Bausch Health Companies Inc.
• 31.8. Perrigo Company plc
• 31.9. Dr Reddy's Laboratories Ltd.
• 31.10. Cipla Ltd.
• 31.11. Amneal Pharmaceuticals Inc.
• 31.12. Mylan N.V.
• 31.13. ALK-Abello
• 31.14. Stallergenes Greer
• 31.15. Allergy Therapeutics

32. Global Anaphylaxis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Anaphylaxis Market

34. Recent Developments In The Anaphylaxis Market

35. Anaphylaxis Market High Potential Countries, Segments and Strategies

• 35.1 Anaphylaxis Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Anaphylaxis Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Anaphylaxis Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer